Achieve Life Sciences, Inc.
Symbol: ACHV (NASDAQ)
4.87
▼ (-4.76%) -0.243
Company Description:
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
Key Stats
- Today's Open: $5.11
- Today's High: $5.17
- Today's Low: $4.855
- Today's Volume: 831.46K
- Yesterday Close: $5.11
- Yesterday High: $5.19
- Yesterday Low: $4.845
- Yesterday Volume: 2.16M
- Last Min Volume: 1.08K
- Last Min High: $4.874
- Last Min Low: $4.865
- Last Min VWAP: $4.86956
Company Profile
- Name: Achieve Life Sciences, Inc.
- Website: https://www.achievelifesciences.com
- Listed Date: 1995-10-12
- Location: SEATTLE, WA
- Market Status: Active
- CIK Number: 0000949858
- SIC Code: 2835
- SIC description: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Market Cap: $263.19M
- Round Lot: 100
- Outstanding Shares: 51.10M
- Asset Type: CS
RECENT FILINGS FOR ACHV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 3 | View |
| 2025-10-07 | 8-K | View |
| 2025-10-03 | 4 | View |
| 2025-09-22 | 4 | View |
| 2025-09-22 | 4 | View |
| 2025-09-19 | 3 | View |
| 2025-09-11 | 8-K | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-06-27 | 8-K | View |
| 2025-06-27 | 424B5 | View |
Latest News on ACHV